N ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG) OSAS SMN10446298

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-12-22 for N ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG) OSAS SMN10446298 manufactured by Siemens Healthcare Diagnostics Products Gmbh.

Event Text Entries

[63108098] Analysis of the instrument and instrument data indicate that the cause for the discordant low csf igg result was antigen excess. The issue was resolved by repeating the sample at a higher dilution as described in the reagent instructions for use. The n antiserum to human igg instructions for use describes the scenario in the limitations of procedure section. The immunoglobulin assays have been designed to minimize antigen excess in the initial sample dilutions. However, it cannot be completely eliminated and in rare cases very high immunoglobulin concentrations may produce falsely-low results. Especially monoclonal immunoglobulins may show reactivity different from the polyclonal standard, which in isolated cases may lead to artificially decreased or non-linear results. In case of serum or plasma determinations, the constellation of igg, iga and igm should be assessed. A check of igg results in csf should be performed by means of ratio diagrams. In case of questionable results, the determinations should be repeated using the next higher sample dilution. The instrument is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


[63108099] A discordant low igg result was obtained on a patient spinal fluid (csf) sample on the bn prospec instrument. The patient result was not reported to the physician. The laboratory repeated the same sample at a higher dilution and a higher result was obtained and reported. Patient treatment was not altered or prescribed based on the initial discordant low csf igg result. There is no indication of any adverse health consequences due to the initial discordant low csf igg result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9610806-2016-00046
MDR Report Key6198574
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-12-22
Date of Report2016-12-22
Date of Event2016-11-22
Date Mfgr Received2016-11-25
Device Manufacturer Date2016-08-02
Date Added to Maude2016-12-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJAMES MORGERA
Manufacturer StreetGLASGOW BUSINESS COMMUNITY PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal197146101
Manufacturer Phone3026318356
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer StreetEMIL VON BEHRING STRASSE 76
Manufacturer CityMARBURG, D-35041
Manufacturer CountryGM
Manufacturer Postal CodeD-35041
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameN ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG)
Generic NameN ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG)
Product CodeCFN
Date Received2016-12-22
Catalog NumberOSAS SMN10446298
Lot Number153025F
Device Expiration Date2018-07-18
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer AddressEMIL VON BEHRING STRASSE 76 MARBURG, D-35041 GM D-35041


Patients

Patient NumberTreatmentOutcomeDate
10 2016-12-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.